Labiotech.eu

News and Trends 16 Jan 2018

Young Oxford Biotech Raises €22.5M to Develop a Universal Flu Vaccine

Vaccitech has closed a Series A fundraising that will support clinical trials with its vaccine technology against influenza and prostate cancer. Spun out from Oxford University in 2016, Vaccitech has now closed its Series A fundraising round. Amounting to a total of £20M (€22.5M), the round was co-led by GV, Oxford Sciences Innovation and Sequoia China, and joined […]

January 16, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Jan 2018

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

Having developed multispecific antibodies with F-star, Denali Therapeutics has joined forces with Takeda Pharmaceuticals to commercialize Alzheimer’s drugs using the technology. F-star’s bispecific antibody technology has received validation in the form of two pharma companies using it for the development of new drugs for neurodegenerative diseases. San Francisco-based Denali Therapeutics and Japanese company Takeda will collaborate on […]

January 15, 2018 - 3 minutesmins - By Alex Dale

News and Trends 15 Jan 2018

The FDA Gives AstraZeneca’s Breast Cancer Drug the Go-Ahead

The UK big pharma company’s Lynparza will be for women with advanced breast cancer that is specifically caused by mutations in the BRCA gene. Global pharma giant AstraZeneca focuses on the development of drugs for cancer, cardiovascular and respiratory diseases. The company, which is working on a number of small molecules and biologics for a […]

January 15, 2018 - 3 minutesmins - By Alex Dale

News and Trends 15 Jan 2018

This is Why You Should Avoid Eating too Much Junk Food

Following last week’s article about the importance of eating plenty of fruit and vegetables, German researchers have unearthed another link between junk food and diabetes and heart disease. Researchers from the University of Bonn, Germany, have found that an unhealthy diet can cause the immune system to act as if it is responding to bacterial […]

January 15, 2018 - 3 minutesmins - By Alex Dale

News and Trends 13 Jan 2018

Mars Astronauts Might Wear Spacesuits Made of Fungi

A team of biodesigners is getting us ready to live on Mars by creating the clothes that future Martians will use using fungi to create the materials. Science fiction has been preparing us for the colonization of Mars for over a century. Many see the planet as an alternative home for when we destroy or overcrowd […]

January 13, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Jan 2018

This Collaboration Will Develop a New Epilepsy Gene Therapy for In-Need Patients

CombiGene and the Cell and Gene Therapy Catapult have struck a deal that will move the biotech’s epilepsy therapy towards the clinic. Swedish biotech CombiGene has combined neuroscience and advances in gene delivery to pioneer and new therapy for epilepsy that has brought down the number of seizures in preclinical studies. The company has joined forces […]

January 12, 2018 - 2 minutesmins - By Alex Dale

News and Trends 12 Jan 2018

These Biomaterials Could Help to Make Stem Cell Therapies a Reality

British researchers have developed biomaterials that better recreate the conditions required for stem cells to grow into desired cell types. Researchers at Imperial College London have used 3D printing to create biological structures that can support tissue regeneration. The study, published in Scientific Reports, outlines how the group used cryogenics – freezing – to create a biomaterial that mimics the […]

January 12, 2018 - 3 minutesmins - By Alex Dale

News and Trends 11 Jan 2018

German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study

The FDA will allow Immunic Therapeutics to commence a Phase II clinical trial to test its oral investigational drug, IMU-838, for the treatment of ulcerative colitis. Immunic Therapeutics, which closed a €31M Series A last September, specializes in the development of drugs for the treatment of chronic inflammatory diseases. At the moment, the company has two ongoing […]

January 11, 2018 - 3 minutesmins - By Alex Dale

News and Trends 11 Jan 2018

Carbios’ Bioplastics Can Now Be Infinitely Recycled at Scale

Scale-up is a major challenge in industrial biotech but Carbios has done it, going large-scale with its recyclable bioplastics technology. Carbios, a young and exciting green chemistry company, aims to find solutions to the environmental and sustainability issues faced by businesses. Since 2012, the company has been leading the THANAPLAST program, which has brought together academic and industrial […]

January 11, 2018 - 3 minutesmins - By Alex Dale

News and Trends 11 Jan 2018

Here’s Another Reason to Eat Plenty of Fruit and Vegetables

Researchers have discovered that bacteria break down fruit and vegetables to produce chemicals that control our genes and could help to prevent cancer and fight infections. British scientists from the Babraham Institute in Cambridge, UK, with colleagues from Brazil and Italy, have discovered a mechanism by which helpful bacteria in the gut can control the […]

January 11, 2018 - 3 minutesmins - By Alex Dale

Inside Labiotech 11 Jan 2018

A Day In The Life of a Labiotech-er

I read the news today oh boy… You read the articles, but what exactly goes on behind the scenes? Here’s a sneak preview of a day in the life of your favorite Labiotech team. 8:00 am: Evelyn, our Editor-in-Chief arrives. Why so early? Because she’s crazy. Also because the early bird gets the worm. 9-9:30 […]

January 11, 2018 - 4 minutesmins - By Katherine Douglas

News and Trends 10 Jan 2018

New Venture Fund Closes $102M to Boost Biotech and Medical Device Development

Truffle Capital has raised $102M (€85M), which will support biotechs, with a focus on medical device companies that have the potential to become market leaders. Truffle Capital, founded in 2001 and based in Paris, is a venture capital firm that focuses on supporting start-ups in life sciences and IT. The company manages assets worth over $1.1B […]

January 10, 2018 - 2 minutesmins - By Alex Dale

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Young Oxford Biotech Raises €22.5M to Develop a Universal Flu Vaccine

British Biotech’s Technology is Taken by Pharma to Fight Alzheimer’s

The FDA Gives AstraZeneca’s Breast Cancer Drug the Go-Ahead

This is Why You Should Avoid Eating too Much Junk Food

Mars Astronauts Might Wear Spacesuits Made of Fungi

This Collaboration Will Develop a New Epilepsy Gene Therapy for In-Need Patients

These Biomaterials Could Help to Make Stem Cell Therapies a Reality

German Biotech Gets FDA Approval to Start an Ulcerative Colitis Phase II Study

Carbios’ Bioplastics Can Now Be Infinitely Recycled at Scale

Here’s Another Reason to Eat Plenty of Fruit and Vegetables

A Day In The Life of a Labiotech-er

New Venture Fund Closes $102M to Boost Biotech and Medical Device Development

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!